Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Neuralstem Inc. Identifier:
First received: April 28, 2011
Last updated: September 23, 2014
Last verified: May 2013